{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:48:23Z","timestamp":1781660903594,"version":"3.54.5"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Council","award":["MR\/L01629X"],"award-info":[{"award-number":["MR\/L01629X"]}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["20083"],"award-info":[{"award-number":["20083"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0224272","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T17:41:57Z","timestamp":1571938917000},"page":"e0224272","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Variation in methods, results and reporting in electronic health record-based studies evaluating routine care in gout: A systematic review"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7337-3527","authenticated-orcid":true,"given":"Samantha S. R.","family":"Crossfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana Yin Hui","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Kingsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1375-1028","authenticated-orcid":true,"given":"Mar","family":"Pujades-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"issue":"13","key":"pone.0224272.ref001","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/jama.2013.393","article-title":"The inevitable application of big data to health care","volume":"309","author":"TB Murdoch","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"pone.0224272.ref002","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"CF Kuo","year":"2015","journal-title":"Nature reviews Rheumatology"},{"issue":"10","key":"pone.0224272.ref003","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"D Khanna","year":"2012","journal-title":"Arthritis care & research"},{"issue":"7","key":"pone.0224272.ref004","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/kex150","article-title":"The British Society for Rheumatology Guideline for the Management of Gout","volume":"56","author":"M Hui","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"pone.0224272.ref005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"P Richette","year":"2016","journal-title":"Annals of the rheumatic diseases"},{"issue":"24","key":"pone.0224272.ref006","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1001\/jama.2014.14484","article-title":"Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England","volume":"312","author":"CF Kuo","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"pone.0224272.ref007","first-page":"661","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"CF Kuo","year":"2014","journal-title":"Annals of the rheumatic diseases"},{"issue":"3","key":"pone.0224272.ref008","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3810\/pgm.2014.05.2774","article-title":"Physician adherence to ACR gout treatment guidelines: perception versus practice","volume":"126","author":"GM Oderda","year":"2014","journal-title":"Postgraduate medicine"},{"issue":"4","key":"pone.0224272.ref009","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/rheumatology\/kev418","article-title":"Impact of gout on the risk of atrial fibrillation","volume":"55","author":"CF Kuo","year":"2016","journal-title":"Rheumatology"},{"key":"pone.0224272.ref010","article-title":"Systematic review of variation in gout medication exposure and its definition and measurement in studies using electronic health records data","author":"S Crossfield","year":"2017","journal-title":"PROSPERO"},{"key":"pone.0224272.ref011","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"BMJ"},{"issue":"21","key":"pone.0224272.ref012","article-title":"How to get started with a systematic review in epidemiology: an introductory guide for early career researchers","volume":"71","author":"HJ Denison","year":"2013","journal-title":"Archives of Public Health"},{"issue":"5","key":"pone.0224272.ref013","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","author":"M Ouzzani","year":"2016","journal-title":"Systematic Reviews"},{"key":"pone.0224272.ref014","unstructured":"Centre for Reviews and Dissemination. Systematic Reviews: CRD\u2019s guidance for undertaking reviews in health care. 2009 [cited 23.03.2017]; https:\/\/www.york.ac.uk\/crd\/guidance\/"},{"issue":"10","key":"pone.0224272.ref015","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/art.39254","article-title":"2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"67","author":"T Neogi","year":"2015","journal-title":"Arthritis & rheumatology"},{"issue":"10","key":"pone.0224272.ref016","first-page":"e1001885","volume":"12","author":"EI Benchimol","year":"2015","journal-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement"},{"key":"pone.0224272.ref017","unstructured":"Cochrane Collaboration. Tool to Assess Risk of Bias in Cohort Studies. [cited 22.01.2018]; http:\/\/methods.cochrane.org\/bias\/sites\/methods.cochrane.org.bias\/files\/public\/uploads\/Tool%20to%20Assess%20Risk%20of%20Bias%20in%20Cohort%20Studies.pdf"},{"key":"pone.0224272.ref018","unstructured":"Care Quality Commission. NHS Patient Survey Programme: Survey scoring method. https:\/\/www.cqc.org.uk\/sites\/default\/files\/20151125_nhspatientsurveys_scoring_methodology.pdf; 2015."},{"issue":"5","key":"pone.0224272.ref019","doi-asserted-by":"crossref","first-page":"e0176178","DOI":"10.1371\/journal.pone.0176178","article-title":"Using the STROBE statement to assess reporting in blindness prevalence surveys in low and middle income countries","volume":"12","author":"J Ramke","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"pone.0224272.ref020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/rheumatology\/keq363","article-title":"Frequency and risk factors of gout flares in a large population-based cohort of incident gout","volume":"50","author":"D Rothenbacher","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"pone.0224272.ref021","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","article-title":"Prevalence of contraindications and prescription of pharmacologic therapies for gout","volume":"124","author":"RT Keenan","year":"2011","journal-title":"Am J Med"},{"issue":"24","key":"pone.0224272.ref022","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1001\/jama.2014.14484","article-title":"Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England","volume":"312","author":"C-F Kuo","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"pone.0224272.ref023","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/rheumatology\/key155","article-title":"Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD)","volume":"57","author":"LEJM Scheepers","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"pone.0224272.ref024","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/rheumatology\/kep332","article-title":"Prescription and comorbidity screening following consultation for acute gout in primary care","volume":"49","author":"E Roddy","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"pone.0224272.ref025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/rheumatology\/keq363","article-title":"Frequency and risk factors of gout flares in a large population-based cohort of incident gout","volume":"50","author":"D Rothenbacher","year":"2011","journal-title":"Rheumatology"},{"issue":"1","key":"pone.0224272.ref026","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-016-1211-y","article-title":"Factors associated with initiation and persistence of urate-lowering therapy","volume":"19","author":"M Dehlin","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"pone.0224272.ref027","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"C-F Kuo","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"pone.0224272.ref028","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2017-212063","article-title":"Work disability in gout: a population-based case-control study","volume":"77","author":"V Sigurdardottir","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"pone.0224272.ref029","doi-asserted-by":"crossref","first-page":"e000326","DOI":"10.1136\/rmdopen-2016-000326","article-title":"Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective","volume":"2","author":"MC Kapetanovic","year":"2016","journal-title":"RMD Open"},{"issue":"2","key":"pone.0224272.ref030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","article-title":"Gout epidemiology: results from the UK General Practice Research Database, 1990\u20131999","volume":"64","author":"TR Mikuls","year":"2005","journal-title":"Annals of the rheumatic diseases"},{"issue":"4","key":"pone.0224272.ref031","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.semarthrit.2016.08.006","article-title":"The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012","volume":"46","author":"SK Rai","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"pone.0224272.ref032","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/annrheumdis-2016-210588","article-title":"The unclosing premature mortality gap in gout: a general population-based study","volume":"76","author":"MC Fisher","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"pone.0224272.ref033","first-page":"2403","article-title":"Epidemiology of gout: is the incidence rising?","volume":"29","author":"E Arromdee","year":"2002","journal-title":"J Rheumatol"},{"issue":"6","key":"pone.0224272.ref034","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/RHU.0b013e3181eeb487","article-title":"Gout in the Hmong in the United States","volume":"16","author":"S Wahedduddin","year":"2010","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"pone.0224272.ref035","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3899\/jrheum.140588","article-title":"Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system","volume":"42","author":"N Rashid","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"pone.0224272.ref036","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjmed.2009.05.026","article-title":"The Dynamics of Chronic Gout Treatment: Medication Gaps and Return to Therapy","volume":"123","author":"LR Harrold","year":"2010","journal-title":"Am J Med"},{"issue":"8","key":"pone.0224272.ref037","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/ard.2008.092619","article-title":"Opportunities for improving medication use and monitoring in gout","volume":"68","author":"JA Singh","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"pone.0224272.ref038","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.40486","article-title":"Allopurinol Dose Escalation and Mortality Among Patients With Gout: A National Propensity-Matched Cohort Study","volume":"70","author":"BW Coburn","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"pone.0224272.ref039","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ijcp.12604","article-title":"Allopurinol adherence among patients with gout: an Italian general practice database study","volume":"69","author":"S Mantarro","year":"2015","journal-title":"International journal of clinical practice"},{"issue":"6","key":"pone.0224272.ref040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/RHU.0000000000000561","article-title":"Allopurinol Medication Adherence as a Mediator of Optimal Outcomes in Gout Management","volume":"23","author":"BW Coburn","year":"2017","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"pone.0224272.ref041","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1060028016679848","article-title":"Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout","volume":"51","author":"JC Hughes","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"3","key":"pone.0224272.ref042","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jbspin.2017.03.013","article-title":"Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study","volume":"85","author":"M Maravic","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"170","key":"pone.0224272.ref043","article-title":"Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice","volume":"14","author":"E Cottrell","year":"2013","journal-title":"BMC Fam Pract"},{"issue":"11","key":"pone.0224272.ref044","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00296-015-3284-3","article-title":"Patient and clinical characteristics associated with gout flares in an integrated healthcare system","volume":"35","author":"N Rashid","year":"2015","journal-title":"Rheumatol Int"},{"issue":"1","key":"pone.0224272.ref045","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1376-z","article-title":"Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study","volume":"19","author":"AJ Landgren","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"pone.0224272.ref046","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3899\/jrheum.121301","article-title":"Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population","volume":"40","author":"K Pui","year":"2013","journal-title":"J Rheumatol"},{"issue":"1","key":"pone.0224272.ref047","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40744-016-0033-3","article-title":"Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis","volume":"3","author":"R Morlock","year":"2016","journal-title":"Rheumatol Ther"},{"issue":"2","key":"pone.0224272.ref048","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0091270012439715","article-title":"Clinical risk factors for adverse events in allopurinol users","volume":"53","author":"H Ryu","year":"2013","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"pone.0224272.ref049","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3810\/pgm.2014.03.2741","article-title":"Achieving Serum Urate Goal: A Comparative Effectiveness Study Between Allopurinol and Febuxostat","volume":"126","author":"H Hatoum","year":"2014","journal-title":"Postgrad Med"},{"key":"pone.0224272.ref050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.amjmed.2018.11.011","article-title":"Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial","author":"TR Mikuls","year":"2019","journal-title":"Am J Med"},{"issue":"5","key":"pone.0224272.ref051","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care for gout in the US needs improvement","volume":"57","author":"JA Singh","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"8","key":"pone.0224272.ref052","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/keh679","article-title":"Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)","volume":"44","author":"TR Mikuls","year":"2005","journal-title":"Rheumatology"},{"issue":"9","key":"pone.0224272.ref053","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00296-017-3777-3","article-title":"Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients","volume":"37","author":"CA Janssen","year":"2017","journal-title":"Rheumatol Int"},{"issue":"7","key":"pone.0224272.ref054","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout","volume":"39","author":"DB Crittenden","year":"2012","journal-title":"J Rheumatol"},{"issue":"9","key":"pone.0224272.ref055","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","article-title":"Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims","volume":"75","author":"DH Solomon","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"pone.0224272.ref056","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.amjmed.2016.12.006","article-title":"Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin","volume":"130","author":"OC Kwon","year":"2016","journal-title":"Am J Med"},{"issue":"12","key":"pone.0224272.ref057","first-page":"2145","article-title":"Effect of allopurinol on all-cause mortality in adults with incident gout: propensity score-matched landmark analysis","volume":"54","author":"CF Kuo","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"pone.0224272.ref058","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2125.1997.00647.x","article-title":"Omeprazole, other antiulcer drugs and newly diagnosed gout","volume":"44","author":"CR Meier","year":"1997","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"pone.0224272.ref059","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data Resource Profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"E Herrett","year":"2015","journal-title":"International journal of epidemiology"},{"key":"pone.0224272.ref060","author":"G Wells","year":"2014","journal-title":"Newcastle-Ottawa quality assessment scale: Cohort studies"},{"key":"pone.0224272.ref061","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"JA Sterne","year":"2016","journal-title":"BMJ"},{"issue":"7","key":"pone.0224272.ref062","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.annepidem.2018.03.008","article-title":"Using electronic health record data for environmental and place based population health research: a systematic review","volume":"28","author":"LH Schinasi","year":"2018","journal-title":"Ann Epidemiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0224272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T04:13:57Z","timestamp":1590120837000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224272"}},"subtitle":[],"editor":[{"given":"Michael","family":"Nurmohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":62,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0224272","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]}}}